Cargando…
870. Coverage, Cost Sharing, and Out-of-Pocket Costs for Single-Tablet HIV Antiretroviral Regimens in Qualified Health Plans in the United States, 2018-2020
BACKGROUND: A key pillar of the US “Ending the HIV Epidemic” (EHE) plan is rapidly providing antiretroviral therapy (ART) to achieve viral suppression. However, access to ART is hindered by discriminatory benefit design through non-coverage, adverse tiering (including pricier cost sharing via coinsu...
Autores principales: | Khazanchi, Rohan, Powers, Samuel D, Killelea, Amy, McManus, Kathleen A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644156/ http://dx.doi.org/10.1093/ofid/ofab466.1065 |
Ejemplares similares
-
Access to a novel first-line single-tablet HIV antiretroviral regimen in Affordable Care Act Marketplace plans, 2018–2020
por: Khazanchi, Rohan, et al.
Publicado: (2023) -
Geographic Variation in Qualified Health Plan Coverage and Prior Authorization Requirements for HIV Preexposure Prophylaxis
por: McManus, Kathleen A., et al.
Publicado: (2023) -
Regional Disparities in Qualified Health Plans’ Prior Authorization Requirements for HIV Pre-exposure Prophylaxis in the United States
por: McManus, Kathleen A., et al.
Publicado: (2020) -
Desimplification of Single Tablet Antiretroviral (ART) Regimens—A Practical Cost-Savings Strategy?
por: Krentz, Hartmut, et al.
Publicado: (2019) -
Formulary tiers, medication cost sharing, and transparency in bronze and silver qualified health plans in 2014 vs 2018
por: Hung, Anna, et al.
Publicado: (2021)